東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Investigations into the genetic and ...

Lakshmanan, Viswanathan.

Linked to FindBook

Google Book

Amazon

博客來

Investigations into the genetic and biochemical basis of chloroquine resistance in malaria parasites.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Investigations into the genetic and biochemical basis of chloroquine resistance in malaria parasites./
Author:	Lakshmanan, Viswanathan.
Description:	174 p.
Notes:	Source: Dissertation Abstracts International, Volume: 66-11, Section: B, page: 5798.
Contained By:	Dissertation Abstracts International66-11B.
Subject:	Biology, Microbiology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3196377
ISBN:	9780542424748

Investigations into the genetic and biochemical basis of chloroquine resistance in malaria parasites.
Lakshmanan, Viswanathan.

Investigations into the genetic and biochemical basis of chloroquine resistance in malaria parasites. - 174 p.

Source: Dissertation Abstracts International, Volume: 66-11, Section: B, page: 5798.

Thesis (Ph.D.)--Yeshiva University, 2006.

Chloroquine resistance (CQR) in the human malaria parasite Plasmodium falciparum has been associated with multiple mutations in the transmembrane protein P. falciparum Chloroquine Resistance Transporter (PfCRT). However, the precise role of the individual PfCRT polymorphisms had previously not been genetically defined. All CQ-resistant parasites express a K76T polymorphism in PfCRT, which has been strongly correlated with in vitro CQR as well as in vivo CQ treatment failure. Nevertheless mutations in additional genes have been postulated to also contribute to resistance. Using allelic exchange, we here show that CQR is critically determined by the single PfCRT polymorphism K76T. Replacement of the mutant threonine with wild-type lysine in PfCRT (generating back-mutant parasite lines) resulted in complete loss of CQR in geographically distinct CQ-resistant lines. Verapamil (VP) chemosensitization of CQR, a characteristic feature of all CQ-resistant lines, was also lost in these lines. Biochemical analyses revealed an increased apparent binding affinity of CQ for its target hematin, which resulted in a significantly increased binding of CQ to hematin in the back-mutant lines. The PfCRT polymorphisms preceding residue 76 were found to dictate the degree of VP chemosensitization of CQR, which differs between CQ-resistant lines. We also discovered that the K76T mutation is tailor-made to confer resistance to drugs that structurally closely resemble CQ, as subtle alterations in the CQ side-chain length can overcome this resistance. Thus, our findings establish the PfCRT K76T mutation as the critical component of CQR and suggest that CQ accessibility and binding to hematin are determined by drug-protein interactions involving this mutant residue. These data validate the use of K76T as a molecular marker of CQR in field-based studies assessing the prevalence of CQR in endemic regions. Also, we have generated transgenic P. berghei expressing both mutant and wild-type pfcrt alleles in the place of its ortholog pfcrt. These recombinant rodent malaria parasites are being used to test whether mutant pfcrt can confer in vivo CQ treatment failure.

ISBN: 9780542424748Subjects--Topical Terms:

1017734
Biology, Microbiology.

Investigations into the genetic and biochemical basis of chloroquine resistance in malaria parasites.
LDR:03083nmm 2200277 4500 001 1826673
005 20061218070911.5
008 130610s2006 eng d
020 $a 9780542424748
035 $a (UnM)AAI3196377
035 $a AAI3196377
040 $a UnM $c UnM
100 1 $a Lakshmanan, Viswanathan. $3 1915630
245 1 0 $a Investigations into the genetic and biochemical basis of chloroquine resistance in malaria parasites.
300 $a 174 p.
500 $a Source: Dissertation Abstracts International, Volume: 66-11, Section: B, page: 5798.
500 $a Adviser: David A. Fidock.
502 $a Thesis (Ph.D.)--Yeshiva University, 2006.
520 $a Chloroquine resistance (CQR) in the human malaria parasite Plasmodium falciparum has been associated with multiple mutations in the transmembrane protein P. falciparum Chloroquine Resistance Transporter (PfCRT). However, the precise role of the individual PfCRT polymorphisms had previously not been genetically defined. All CQ-resistant parasites express a K76T polymorphism in PfCRT, which has been strongly correlated with in vitro CQR as well as in vivo CQ treatment failure. Nevertheless mutations in additional genes have been postulated to also contribute to resistance. Using allelic exchange, we here show that CQR is critically determined by the single PfCRT polymorphism K76T. Replacement of the mutant threonine with wild-type lysine in PfCRT (generating back-mutant parasite lines) resulted in complete loss of CQR in geographically distinct CQ-resistant lines. Verapamil (VP) chemosensitization of CQR, a characteristic feature of all CQ-resistant lines, was also lost in these lines. Biochemical analyses revealed an increased apparent binding affinity of CQ for its target hematin, which resulted in a significantly increased binding of CQ to hematin in the back-mutant lines. The PfCRT polymorphisms preceding residue 76 were found to dictate the degree of VP chemosensitization of CQR, which differs between CQ-resistant lines. We also discovered that the K76T mutation is tailor-made to confer resistance to drugs that structurally closely resemble CQ, as subtle alterations in the CQ side-chain length can overcome this resistance. Thus, our findings establish the PfCRT K76T mutation as the critical component of CQR and suggest that CQ accessibility and binding to hematin are determined by drug-protein interactions involving this mutant residue. These data validate the use of K76T as a molecular marker of CQR in field-based studies assessing the prevalence of CQR in endemic regions. Also, we have generated transgenic P. berghei expressing both mutant and wild-type pfcrt alleles in the place of its ortholog pfcrt. These recombinant rodent malaria parasites are being used to test whether mutant pfcrt can confer in vivo CQ treatment failure.
590 $a School code: 0266.
650 4 $a Biology, Microbiology. $3 1017734
650 4 $a Biology, Genetics. $3 1017730
690 $a 0410
690 $a 0369
710 2 0 $a Yeshiva University. $3 1017732
773 0 $t Dissertation Abstracts International $g 66-11B.
790 1 0 $a Fidock, David A., $e advisor
790 $a 0266
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3196377